In the intervention group, there were improvements ranging from 10 to 20 percentage points in the proportion of participants providing specific diabetes services: diabetes classification, insulin treatment, oral hypoglycemic agents, early control for T2DM, T2DM complication treatment, and T2DM non-drug treatment. The gene discussed is INS; the disease is diabetes mellitus.